Fig 1.
CONSORT participant flow diagram.
Table 1.
General clinical data of 88 patients with NPC.
Table 2.
Incidence of grade 3 neutropenia during concurrent chemoradiotherapy.
Fig 2.
Changes in the white blood cell count.
Fig 3.
Changes in the neutrophil count.
Table 3.
Repeated measures analysis of variance (RM-ANOVA) of ANC changes between experimental and control groups during concurrent chemoradiotherapy.
Fig 4.
Changes in the platelet count.
Fig 5.
Changes in the hemoglobin.
Table 4.
Rate of chemotherapy delay and interruption of radiotherapy during concurrent chemoradiotherapy.
Table 5.
Incidence of oral mucositis during concurrent chemoradiotherapy.
Fig 6.
WBC and ANC on day 7 post-chemotherapy.